Study points to new way to activate immune system in kidney cancer
The study could pave the way for a new combination therapeutic strategy in clear cell renal cell carcinoma.
The study could pave the way for a new combination therapeutic strategy in clear cell renal cell carcinoma.
UF Health Cancer Institute researchers have created a novel drug that shows promise for the treatment of aggressive AML.
UF Health researchers developed a digital tool that uses artificial intelligence to accelerate the diagnosis of acute leukemias.
The score could be used to identify patients more likely to have worse outcomes and optimize their treatment.
The findings could help develop new treatments to overcome resistance to chemotherapy.
Using patients’ own genetics to tailor their chemotherapy regimens appears to improve outcomes in children with acute myeloid leukemia.
The National Cancer Institute has awarded Jatinder Lamba, Ph.D., M.Sc., a professor of pharmacotherapy and translational research in the University of Florida College of Pharmacy and a member of the UF Health Cancer Center, a five-year, $1.9 million grant titled, “Genomics of AML Prognosis,” to continue research on Acute Myeloid Leukemia, or AML, that began in 2008.